Barclays
OPK icon

Barclays’s Opko Health OPK Stock Holding History

Barclays’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,200
Closed -$2K – 6371
2019
Q4 		$2K Hold
1,200
– – ﹤0.01% 6245
2019
Q3 		$3K Hold
1,200
– – ﹤0.01% 6511
2019
Q2 		$3K Hold
1,200
– – ﹤0.01% 6769
2019
Q1 		$3K Sell
1,200
-20,100
-94% -$60.9K ﹤0.01% 6810
2018
Q4 		$64K Sell
21,300
-38,400
-64% -$130K ﹤0.01% 5341
2018
Q3 		$207K Buy
59,700
+23,000
+63% +$122K ﹤0.01% 4969
2018
Q2 		$172K Buy
36,700
+1,300
+4% +$4.93K ﹤0.01% 4844
2018
Q1 		$112K Sell
35,400
-97,900
-73% -$394K ﹤0.01% 5306
2017
Q4 		$653K Buy
133,300
+2,100
+2% +$12.2K ﹤0.01% 3541
2017
Q3 		$900K Buy
131,200
+63,200
+93% +$398K ﹤0.01% 3098
2017
Q2 		$447K Buy
68,000
+25,000
+58% +$175K ﹤0.01% 3636
2017
Q1 		$344K Sell
43,000
-30,200
-41% -$254K ﹤0.01% 3779
2016
Q4 		$681K Buy
73,200
+14,700
+25% +$152K ﹤0.01% 3105
2016
Q3 		$620K Buy
58,500
+33,900
+138% +$338K ﹤0.01% 3049
2016
Q2 		$230K Sell
24,600
-216,300
-90% -$2.2M ﹤0.01% 3826
2016
Q1 		$2.41M Sell
240,900
-4,834,275
-95% -$44.2M ﹤0.01% 1751
2015
Q4 		$50.8M Sell
5,075,175
-748,500
-13% -$7.5M 0.06% 276
2015
Q3 		$46.6M Sell
5,823,675
-1,246,225
-18% -$16.5M 0.06% 301
2015
Q2 		$113M Buy
7,069,900
+725,100
+11% +$11.3M 0.13% 126
2015
Q1 		$88.8M Buy
6,344,800
+3,490,700
+122% +$45.4M 0.1% 178
2014
Q4 		$25.7M Buy
2,854,100
+1,051,200
+58% +$9M 0.02% 636
2014
Q3 		$14.4M Sell
1,802,900
-1,316,300
-42% -$11.6M 0.01% 920
2014
Q2 		$25M Buy
3,119,200
+589,500
+23% +$5.15M 0.03% 587
2014
Q1 		$22.8M Sell
2,529,700
-834,100
-25% -$7.31M 0.03% 616
2013
Q4 		$26.9M Buy
3,363,800
+2,359,300
+235% +$23.8M 0.03% 599
2013
Q3 		$8.04M Buy
1,004,500
+214,700
+27% +$1.72M 0.01% 1316
2013
Q2 		$5.61M Buy
+789,800
New +$5.45M 0.01% 1527

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays's OPK Position: Q1 2026 in Review

Barclays reduced its Opko Health (OPK) stake by 79% in Q1 2026, selling an estimated $646K and leaving 138,300 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

Barclays first reported a position in OPK in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.4M in Q4 2015. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Barclays held 138,300 shares of Opko Health worth $158K as of Q1 2026.
  • Barclays sold 524,936 Opko Health shares in Q1 2026, an estimated $646K.
  • Opko Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3826 holding.
  • Barclays first reported a position in Opko Health in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Opko Health position peaked at $19.4M in Q4 2015.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.